Loading...
The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection. Recently, with the rapid expansion of the bDMARDs market in Korea, reports of serious adverse events...
Na minha lista:
| Udgivet i: | Korean J Intern Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Association of Internal Medicine
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6960050/ https://ncbi.nlm.nih.gov/pubmed/31935319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2019.411 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|